S100A12 and metabolic syndrome: Firstly, this study for the first time found a significant correlation between S100A12 and the risk of PAD among patients with dyslipidemia, confirming that S100A12 plays an important role in the atherosclerotic process of peripheral arteries induced by LDL-C.